3716 Stock Overview
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Cenra Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$37.55 |
| 52 Week High | NT$44.55 |
| 52 Week Low | NT$35.50 |
| Beta | 0 |
| 1 Month Change | -0.53% |
| 3 Month Change | -6.94% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -10.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3716 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | 4.7% | 2.8% | 3.2% |
| 1Y | n/a | -0.02% | 27.5% |
Return vs Industry: Insufficient data to determine how 3716 performed against the TW Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 3716 performed against the TW Market.
Price Volatility
| 3716 volatility | |
|---|---|
| 3716 Average Weekly Movement | 2.5% |
| Pharmaceuticals Industry Average Movement | 3.5% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.7% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 3716 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: Insufficient data to determine 3716's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | n/a | Hou-Kai Wang | www.cenra.com |
Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It offers active pharmaceutical ingredients, generic drugs for human use, over to the counter drugs, self-care products for the prevention of diseases, home care and cosmetics, and animal healthcare products. The company is also involved in the research and development, contracting manufacturing and international, and senior care services, as well as distributes and sells pharmaceutical brands.
Cenra Inc. Fundamentals Summary
| 3716 fundamental statistics | |
|---|---|
| Market cap | NT$5.58b |
| Earnings (TTM) | NT$371.76m |
| Revenue (TTM) | NT$8.94b |
15.0x
P/E Ratio0.6x
P/S RatioIs 3716 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3716 income statement (TTM) | |
|---|---|
| Revenue | NT$8.94b |
| Cost of Revenue | NT$5.62b |
| Gross Profit | NT$3.31b |
| Other Expenses | NT$2.94b |
| Earnings | NT$371.76m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.50 |
| Gross Margin | 37.10% |
| Net Profit Margin | 4.16% |
| Debt/Equity Ratio | 37.7% |
How did 3716 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 03:54 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cenra Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wei Zheng Kit | Citigroup Inc |
| Ryan Liu | IBTS Investment Consulting Co., Ltd. |
| Regina Lee | Jih Sun Securities Investment Consulting Co., Ltd. |